Showing results (31-40 of 412) with videos related to
Sort By:
Pageof 42
British Journal of Haematology|December 19, 2014
Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results databaseJorge J Castillo, Adam J Olszewski, Sandra Kanan, et al.Blood Advances|July 17, 2025
Ibrutinib plus rituximab versus ibrutinib monotherapy in patients with Waldenström macroglobulinemia: A pooled analysisAlberto Guijosa, Andres Ramirez-Gamero, Shayna Sarosiek, et al.Ejhaem|September 2, 2022
A pilot study on dasatinib in patients with Waldenström macroglobulinemia progressing on ibrutinibJorge J Castillo, Shayna Sarosiek, Catherine A Flynn, et al.Blood Advances|October 21, 2025
Familial Clusters and Clinical Features, Complications, and Outcomes in 1000 Patients with Waldenström MacroglobulinemiaAndres Ramirez-Gamero, Nickolas Tsakmaklis, Zachary R Hunter, et al.British Journal of Haematology|January 10, 2023
Dose reductions in patients with Waldenström macroglobulinaemia treated with ibrutinibShayna Sarosiek, Joshua N Gustine, Catherine A Flynn, et al.American Journal of Hematology|December 28, 2017
Ibrutinib discontinuation in Waldenström macroglobulinemia: Etiologies, outcomes, and IgM reboundJoshua N Gustine, Kirsten Meid, Toni Dubeau, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2018
Prospective Clinical Trial of Ixazomib, Dexamethasone, and Rituximab as Primary Therapy in Waldenström MacroglobulinemiaJorge J Castillo, Kirsten Meid, Joshua N Gustine, et al.British Journal of Haematology|May 10, 2017
Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemiaJoshua N Gustine, Kirsten Meid, Toni Dubeau, et al.Pageof 42